About this trial
Persistent pain after colorectal surgery remains a significant clinical challenge that can delay recovery, reduce quality of life, and increase long-term healthcare burden. The goal of this study is to gain a deeper understanding of the biological and clinical factors that influence pain severity after colorectal surgery and contribute to the transition from acute to chronic postoperative pain. Guided by a biopsychosocial framework, this research will address the following aims:
1. The investigators will use standardized experimental pain testing before surgery to evaluate how patients respond to different types of controlled sensory stimuli. These responses may help predict who is more likely to experience severe or prolonged pain after surgery. 2. The investigators will analyze blood samples collected before and after surgery to measure markers of inflammation and other biological responses. These data will help us explore how the body's immune and hormonal systems relate to pain severity in both the short- and longer-term recovery phases. 3. The investigators will assess psychological and clinical factors, such as emotional health, coping style, household income, and life stressors, to understand how they contribute to patients' pain experiences throughout recovery. 4. The investigators will examine whether routinely collected demographic and clinical characteristics can help identify patients at greater risk of experiencing higher levels of pain after surgery. This approach will allow us to better understand which patients may benefit from more tailored perioperative pain management strategies.
Eligibility criteria
Qualifiers
Participants scheduled for colorectal cancer surgery
Age between 18-65; 3)
Understanding verbal and written English
Disqualifiers
Concurrent medical conditions that could confound the interpretation of the data
Human immunodeficiency virus positive diagnosis
Cardiovascular or pulmonary disease
Systemic rheumatoid disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator